Vericel (VCEL) Free Cash Flow (2010 - 2026)
Vericel's (VCEL) quarterly Free Cash Flow came in at $14.9 million in Q1 2026, up 296.03% year-on-year from $3.8 million in Q1 2025, and up 16.33% quarter-over-quarter from $12.8 million in Q4 2025.
Vericel (VCEL) Free Cash Flow (2010 - 2026) Analysis & Trends
Vericel has disclosed Free Cash Flow across 17 years of filings, most recently posting $14.9 million for Q1 2026.
- Free Cash Flow for Q1 2026 came in at $14.9 million, up 296.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $47.3 million (up 815.53% YoY), and the FY2025 annual result was $24.7 million, up 525.88% from the prior year.
- Free Cash Flow came in at $14.9 million for Q1 2026 at Vericel, up from $12.8 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $21.0 million in Q2 2025 to a low of -$26.8 million in Q3 2024.
- The 5-year median for Free Cash Flow is $5.4 million (2022), against an average of $3.5 million.
- Across the five-year window, Free Cash Flow jumped 1341.34% in 2023 and plunged 3793.9% in 2024, its largest moves.
- Vericel's Free Cash Flow stood at $5.8 million in 2022, then slumped by 61.52% to $2.3 million in 2023, then surged by 275.61% to $8.5 million in 2024, then soared by 51.71% to $12.8 million in 2025, then climbed by 16.33% to $14.9 million in 2026.
- The last three Free Cash Flow figures came in at $14.9 million (Q1 2026), $12.8 million (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 14.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.92 Mn |
| Mar 31, 2026 | 14.92 Mn |
| Dec 31, 2025 | 12.83 Mn |
| Dec 31, 2025 | 12.83 Mn |
| Sep 30, 2025 | -1.45 Mn |
| Sep 30, 2025 | -1.45 Mn |
| Jun 30, 2025 | 20.99 Mn |
| Jun 30, 2025 | 20.99 Mn |
| Mar 31, 2025 | -7.61 Mn |
| Mar 31, 2025 | -7.61 Mn |
| Dec 31, 2024 | 8.46 Mn |
| Dec 31, 2024 | 8.46 Mn |
| Sep 30, 2024 | -26.79 Mn |
| Sep 30, 2024 | -26.79 Mn |
| Jun 30, 2024 | 19.34 Mn |
| Jun 30, 2024 | 19.34 Mn |
| Mar 31, 2024 | -6.82 Mn |
| Mar 31, 2024 | -6.82 Mn |
| Dec 31, 2023 | 2.25 Mn |
| Dec 31, 2023 | 2.25 Mn |